The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 07, 2025
Filed:
Jul. 09, 2021
Applicant:
Crispr Therapeutics Ag, Zug, CH;
Inventors:
Roman Lvovitch Bogorad, Cambridge, MA (US);
Chad Albert Cowan, Cambridge, MA (US);
Ante Sven Lundberg, Cambridge, MA (US);
Assignee:
CRISPR THERAPEUTICS AG, Zug, CH;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 48/00 (2006.01); A61K 9/00 (2006.01); C12N 5/071 (2010.01); C12N 5/0775 (2010.01); C12N 15/10 (2006.01); C12N 15/113 (2010.01); C12N 15/90 (2006.01);
U.S. Cl.
CPC ...
A61K 48/0058 (2013.01); A61K 9/0019 (2013.01); A61K 48/005 (2013.01); A61K 48/0066 (2013.01); A61K 48/0075 (2013.01); C12N 5/0663 (2013.01); C12N 5/067 (2013.01); C12N 15/102 (2013.01); C12N 15/1138 (2013.01); C12N 15/907 (2013.01); C12N 2310/20 (2017.05);
Abstract
Materials and methods for treating a patient with hereditary hemochromatosis (HHC), both ex vivo and in vivo, and materials and methods for modulating the expression, function, or activity of a haemochromatosis (HFE) gene in a cell by genome editing.